Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Human Cloning Policy Institute Spearheads Global Grassroots Effort to Prevent Therapeutic Cloning Ban at the United Nations

06.11.2003


The Human Cloning Policy Institute (HCPI) launched this week a major grassroots effort to head off a proposed ban on therapeutic cloning in the United Nations scheduled for vote this Thursday. The total ban is sponsored by Costa Rica and is supported by the United States. The Human Cloning Policy Institute is backed by Ian Wilmut (Dolly’s cloner), some of the world’s leading scientists, physicians and international law experts, including retired World Court judge, C.G. Weeramantry.

HCPI executive director, Bernard Siegel stated, “It is the widespread belief of leading scientists and medical researchers that failure to proceed with SCNT stem cell research is the equivalent to turning our backs on one of the greatest potential medical advances of our time and would thereby destroy the hope for understanding and treatment of many deadly diseases and conditions. A consequence of banning SCNT research might be to condemn millions of adults and children to premature death or a life of intense misery and suffering.”

HCPI has urged its supporters and allied organizations, including disease advocates, private citizens, members of biotechnology organizations, physicians, lawyers and members of the scientific research community, to support passage of UN initiatives outlawing human reproductive cloning, but which allow for the promise of SCNT. It opposes the Costa Rican proposed convention, which bans SCNT research and urges support for the rival Belgium compromise convention, which encourages member states to ban reproductive cloning, but would not ban SCNT internationally.



HCPI further urges support for the World Court Initiative asking the General Assembly to seek an advisory opinion from the International Court of Justice declaring human reproductive cloning (only) a crime against humanity. Siegel stated, “By sponsoring the World Court Initiative, HCPI seeks that the World Court strip away any vestige of legitimacy from potential human cloners, such as Zavos and Antinori. A declaration that human reproductive cloning is a crime against humanity will prompt all member states to crack down on those activities and serve as a lasting deterrent.”

Siegel further commented, “Human reproductive cloning activities performed by unscrupulous scientists are human experimentation. No individual scientist, corporation, business enterprise or nation has the moral or legal warrant to clone human beings. It is extremely important to recognize the difference between reproductive and therapeutic cloning. Informed scientific opinion worldwide supports therapeutic cloning of stem cells. The American Medical Association, the National Academy of Sciences, the Association of American Universities, and many other medical, scientific, and educational associations endorse therapeutic cloning.”

Supporters of HCPI have been urged to email the UN missions at mission@un.org, to express their views on the current proposals. Organizations allied with HCPI on this initiative include the Stem Cell Action Network (SCAN) which has emailed a petition to all UN missions, signed by 2,200 teachers and scientists in medical schools and university science departments across the United States in favor of therapeutic cloning research. The Committee for Advancement of Stem Cell Research (CASCR) also supports the initiative. Both organizations are members of the Coalition for the Advancement of Medical Research.

Frank Cocozzelli, CASCR executive director, who suffers from a form of muscular dystrophy said, “Along with millions of other world citizens who are disabled, suffering from a catastrophic illness or both, SCNT offers me one of the first real rays of hope of being healed.”

The Human Cloning Policy Institute (HCPI) is a nonprofit organization dedicated to advocacy, education and policies against reproductive cloning, while preserving SCNT (therapeutic cloning) which holds the promise of understanding and treating some of man’s deadliest diseases.

HCPI’s principal supporters are leading stem cell scientists, researchers and physicians, who are members of the group’s science and medical advisory boards. A partial list includes: Dr. Ian Wilmut (Roslin Institute), Dr. Rudolf Jaenisch (Whitehead Institute- MIT), Dr. Douglas Melton (Harvard), Dr. Lawrence Goldstein (UCSD), Dr. Gerald Schatten (Magee College), Dr. Alan Trounson ( Monash- Australia), Camillo Ricordi, MD (Diabetes Research Institute), Dr. Helena Edlund (Sweden), Dr. W.Dalton Dietrich (Miami Project to Cure Paralysis), Joe Massey, MD. (Reproductive expert-Atlanta), Judith Grossberg, M.D. (pediatrics-MCV),Doris Rapp, MD ( best-selling author), Sidney Ikpe (International Hospital Relief Foundation), Torrey Brown, MD (Intralytix, Inc., Baltimore) and Dr. Barry Smernoff (Cleveland).

HCPI also has the support of a human rights-legal advisory board that includes retired World Court Judge Christopher Weeramantry (Sri Lanka), law professor Richard Falk (Princeton-UCSB), Peter Ludwig (Darby & Darby-New York) and Nihal Jayawickrama (University of London, School of Economics).

Bernard Siegel | alfa
Further information:
http://www.clonelaw.org

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>